載入...
A96 ADALIMUMAB FOR MAINTENANCE OF REMISSION IN CROHN’S DISEASE
BACKGROUND: Maintenance of remission of Crohn’s disease (CD) is a clinically important goal, as disease relapse can negatively affect quality of life. AIMS: The objective of this systematic review was to assess the efficacy and safety of adalimumab for maintenance of remission in patients with quies...
Na minha lista:
| 發表在: | J Can Assoc Gastroenterol |
|---|---|
| Main Authors: | , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Oxford University Press
2019
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6512699/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jcag/gwz006.095 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|